ARV-1803

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameARV-1803
Drug Alias NameARV-1803
ClassificationOther
Mechanisms of ActionLeptin receptor agonists
TargetsLeptin receptor
Therapy Area/IndicationsBreast NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTemple University
China Registration ClassN/A

Develop Information

Active CompaniesTemple University
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A